NATIENS: Optimal Management and Mechanisms of SJS/TEN
Public ClinicalTrials.gov record NCT02987257. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
NATIENS: A Phase III Randomized Double-Blinded Placebo Controlled Study to Determine the Optimal Management and Mechanisms of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Study identification
- NCT ID
- NCT02987257
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Vanderbilt University Medical Center
- Other
- Enrollment
- 2 participants
Conditions and interventions
Interventions
- Etanercept 50 mg sc day 1 and day 4 Drug
- Harmonized supportive care Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 20, 2023
- Primary completion
- Oct 30, 2025
- Completion
- Oct 30, 2025
- Last update posted
- Dec 16, 2025
2023 – 2025
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Valleywise Health Medical Center | Phoenix | Arizona | 85008 | — |
| University of California, Davis Medical Center | Sacramento | California | 95817 | — |
| MedStar Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| University of Florida Health Burn Center | Gainesville | Florida | 32610 | — |
| University of Miami, Ryder Trauma Center | Miami | Florida | 33136 | — |
| Emory University at Grady Memorial Hospital | Atlanta | Georgia | 30303 | — |
| Loyola University Medical Center | Maywood | Illinois | 60153 | — |
| Johns Hopkins Bayview Medical Center | Baltimore | Maryland | 21224 | — |
| Wayne State University | Detroit | Michigan | 48201 | — |
| University of Tennessee Health Sciences Center | Memphis | Tennessee | 38103 | — |
| Vanderblt University Medical Center | Nashville | Tennessee | 37232 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| University of Texas Medical Branch | Galveston | Texas | 77555 | — |
| University of Washington, Harborview Medical Center | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02987257, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 16, 2025 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02987257 live on ClinicalTrials.gov.